No Data
Stocks that moved and those that were traded in the front market.
* Komatsu Wall <7949> 1780 - The significant increase in the dividend plan raises the appeal of the yield. * Sumitomo Pharma <4506> 787 +100 The substantial upward revision beyond expectations has an impact. * Square Enix HD <9684> 8121 +993 3D Investment emerged as a major shareholder. * S.M.S <2175> 1360 +168 The forecast of double-digit profit growth this period and the strengthening of shareholder returns are well received. * Genky Drug Stores <9267> 3630 +42
Genki Dora surged to an all-time high since the beginning of the year, with the FY2025 third quarter results landing on increased revenue and profit.
Genky DrugStores (ゲンキードラ) <9267.T> surged sharply. At one point, it rose by 470 yen to 3,675 yen, significantly updating the year-to-date high of 3,460 yen on the 24th. After the market closed on the 28th, the consolidated financial results for the third quarter of the fiscal year ending June 2025 (June 21, 2024 - March 20, 2025) were announced. The results showed an increase in both revenue and operating profit, which was well received. The third quarter financial results showed revenue of 147.83 billion yen (a 7.9% increase compared to the same period last year) and operating profit of 6.839 billion yen (a 5.3% increase compared to the same period last year). Concentration.
The Nikkei average is up about 50 yen, and after buying, it shows heavy movement at the upper levels = 30 days before the morning session.
On the 30th at 10:08 AM, the Nikkei average stock price fluctuated around 35,890 yen, down about 50 yen compared to the previous trading day. At 9:09 AM, it reached 36,023 yen 24 sen, up 183 yen 25 sen. In the U.S. market on the 29th, the announcement by the U.S. government to reduce tariffs on imported components for completed vehicles produced domestically was well received, leading to the Dow Inc rising for the sixth consecutive day and a rebound in the Nasdaq Composite Index. Japanese stocks also saw buying ahead of the rise in U.S. stocks. However, after the initial buying settled down.
Key points of attention for the PTS on the 28th = SMS, Kikkoman, Sekisui House.
▽ SMS <2175.T>, Earnings Reports and Stock Buyback ▽ Kikkoman <2801.T>, Earnings Reports and Increased Dividends and Stock Buyback ▽ Sekisui Chemical <4204.T>, Earnings Reports and Revision of Financial Estimates and Stock Buyback ▽ Autech <1736.T>, Revision of Performance and Financial Estimates ▽ Kudo Construction <1764.T>, Acquisition of Stocks of Matsushita Industrial (Subsidiarization) ▽ Marudai Food <2288.T>, Revision of Performance Estimates and Special Loss Recording ▽ Core <2359.T>, Earnings Reports and Review of Medium-term Management Plan Objectives
Genky DrugStores Reports Strong Financial Performance for Nine Months Ending March 2025
Genky Drug Stores: Supplementary explanatory materials for the 3rd quarter of the fiscal year ending 2025/6
